Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

被引:32
|
作者
Rombouts, Eva K. [1 ]
Rosendaal, Frits R. [1 ,2 ]
van der Meer, Felix J. M. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
关键词
anticoagulation; vitamin K; vitamin K antagonists; diet; international normalized ratio; ATRIAL-FIBRILLATION; RISK-FACTORS; WARFARIN; VKORC1; OVERANTICOAGULATION; VARIABILITY; CYP2C9; SUPPLEMENTATION; ACENOCOUMAROL; MANAGEMENT;
D O I
10.1111/j.1365-2141.2010.08108.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>It is unclear what advice should be given to patients using vitamin K antagonists with respect to dietary vitamin K intake. We performed a nested case-control study in patients attending a Dutch anticoagulation clinic, to determine the association between vitamin K intake and subtherapeutic International Normalized Ratio (INR) values and the interaction between usual and recent vitamin K intake. Compared to patients with a normal usual vitamin K intake, those with a high vitamin K intake had a decreased risk of a subtherapeutic INR [Hazard Ratio (HR) 0 center dot 80, 95% confidence interval (CI): 0 center dot 56-1 center dot 16] and patients with a low vitamin K intake an increased risk (HR 1 center dot 33, 95% CI: 0 center dot 79-2 center dot 25). In patients with a low usual vitamin K intake, recent vitamin K intake was twice as high in cases as in controls (164 vs. 85 mu g/d). Such a difference was not observed in patients with a normal or high usual vitamin K intake. Our results suggest that a high vitamin K intake reduces the risk of a low INR by lessening the influence of incidental consumption of vitamin K rich food on the INR. These findings support the recommendation for patients on vitamin K antagonists to eat a sufficient amount of vitamin-K containing foods.
引用
收藏
页码:598 / 605
页数:8
相关论文
共 50 条
  • [41] Dietary intake and plasma concentrations of vitamin K-1.
    Booth, SL
    Davidson, KW
    OBrien, ME
    Tucker, K
    Sadowski, JA
    FASEB JOURNAL, 1996, 10 (03): : 3037 - 3037
  • [42] Vitamin K: dietary intake and requirements in different clinical conditions
    Harshman, Stephanie G.
    Saltzman, Edward
    Booth, Sarah L.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (06): : 531 - 538
  • [43] Dietary Intake of Vitamin K Is Inversely Associated with Mortality Risk
    Juanola-Falgarona, Marti
    Salas-Salvado, Jordi
    Angel Martinez-Gonzalez, Miguel
    Corella, Dolores
    Estruch, Ramon
    Ros, Emili
    Fito, Montserrat
    Aros, Fernando
    Gomez-Gracia, Enrique
    Fiol, Miquel
    Lapetra, Jose
    Basora, Josep
    Maria Lamuela-Raventos, Rosa
    Serra-Majem, Lluis
    Pinto, Xavier
    Angel Munoz, Miguel
    Ruiz-Gutierrez, Valentina
    Fernandez-Ballart, Joan
    Bullo, Monica
    JOURNAL OF NUTRITION, 2014, 144 (05): : 743 - 750
  • [44] Vitamin K Intake in Chronic Stroke: Implications for Dietary Recommendations
    Wessinger, Chad
    Hafer-Macko, Charlene
    S. Ryan, Alice
    NUTRIENTS, 2020, 12 (10) : 1 - 10
  • [45] GUIDELINE ADHERENCE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANT THERAPY: RESULTS FROM RAMSES STUDY
    Basaran, O.
    Dogan, V.
    Biteker, M.
    Beton, O.
    Tekinalp, M.
    Bolat, I.
    Tasar, O.
    Kalcik, M.
    Kalaycioglu, E.
    Aykan, A. C.
    Safak, O.
    Yaman, M.
    Inci, S.
    Altintas, B.
    Kalkan, S.
    Karadeniz, F.
    Altun, I.
    Soylu, M. O.
    THROMBOSIS RESEARCH, 2016, 141 : S7 - S8
  • [46] Non-vitamin K antagonist oral anticoagulant therapy in a patient with atrial fibrillation and concomitant prostate cancer
    Slawinski, Grzegorz
    Lewicka, Ewa
    Raczak, Grzegorz
    KARDIOLOGIA POLSKA, 2016, 74 : 55 - 57
  • [47] Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy
    Akiyama, Hisanao
    Uchino, Kenji
    Hasegawa, Yasuhiro
    PLOS ONE, 2015, 10 (07):
  • [48] Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged
    Wentzien, TH
    O'Reilly, RA
    Kearns, PJ
    CHEST, 1998, 114 (06) : 1546 - 1550
  • [49] Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy
    Nijole Bernaitis
    Tony Badrick
    Andrew K. Davey
    Julia Crilly
    Shailendra Anoopkumar-Dukie
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 461 - 465
  • [50] Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy
    Takahashi, Haruhiko
    Jimbo, Yasushi
    Takano, Hiroki
    Abe, Hiroshi
    Sato, Masahito
    Fujii, Yukihiko
    Aizawa, Yoshifusa
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (02): : 222 - 225